An op-ed published by MedPage Today in 2023 that called for more aggressive enforcement of the data reporting law said the ...
By Siddhi Mahatole and Unnamalai L April 13 (Reuters) - The U.S. Food and Drug Administration has approved the expanded use ...
FDA officials said an internal analysis found results were not submitted for nearly 30% of studies “highly likely” to fall ...
Espresso Malted Milk Balls sold nationwide were recalled after undeclared wheat and soy were found. The FDA classified the ...
A CNBC investigation revealed the proliferation of AFPs, which import prescription drugs from overseas in what U.S.
FDA Commissioner Marty Makary has said the agency needs “giant, big ideas” to counter China’s dominance in early-stage ...
FDA updates mifepristone safety study status, detailing ongoing data evaluation and potential changes to the REMS program amid legal challenges.
Constant leadership changes and erratic decision-making have left the biopharmaceutical industry feeling its chief regulator ...
SAN FRANCISCO, April 13, 2026 (GLOBE NEWSWIRE) -- ProSomnus Sleep Technologies (“the Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy® and pioneer in Smart Sleep Medicine™, today ...
US regulators have withdrawn their approval of a GSK Plc drug that the Trump administration had promoted as a treatment for ...
The FDA has announced a voluntary recall of several cough drops and throat lozenges sold nationwide. Here are the brands ...
Food and Drug Administration has approved the expanded use of Travere Therapeutics' drug to treat a rare kidney disorder, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results